Clinical Trials for Nasopharyngeal Carcinoma

Find clinical trials for nasopharyngeal carcinoma. Discover research opportunities and treatment options in your area.

140 Active Trials Found

Showing 140 trials on this page

Page 1 of 7

Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)

NCT ID: NCT05721222

This clinical trial, called PRO1160-001, is researching a new drug named PRO1160 for patients with advanced solid tumors or certain types of blood cancers, specifically Renal Cell Carcinoma (a type...

Recruiting

Phase: PHASE1 Type: interventional Locations: Ann Arbor, Michigan, United States, Portland, Oregon, United States +33 more

Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

NCT ID: NCT05147844

This clinical trial is exploring the use of a medication called toripalimab in combination with radiotherapy to treat a specific type of cancer known as nasopharyngeal carcinoma (NPC) that has spre...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chongqing, Chongqing, China, Chongqing, Chongqing, China

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

NCT ID: NCT05544929

This clinical trial is exploring the safety and effectiveness of a new treatment called KFA115, both on its own and in combination with another medication called pembrolizumab, for patients with ce...

Recruiting

Phase: PHASE1 Type: interventional Locations: Toronto, Ontario, Canada, Pittsburgh, Pennsylvania, United States +24 more

Screening for Early Diagnosis of Nose Cancer

NCT ID: NCT07019870

This clinical trial is focused on finding out how effective screening methods are for detecting nasopharyngeal cancer (NPC), a type of nose cancer, early on. Researchers are particularly interested...

Recruiting

Phase: NA Type: interventional Locations: Singapore, , Singapore, Singapore, , Singapore

Phase III Non-Inferiority Trial of Proton Versus Photon Therapy for Nasopharyngeal Carcinoma

NCT ID: NCT07000643

This clinical trial is comparing two types of radiation therapy for patients with nasopharyngeal carcinoma, a type of cancer that affects the area behind the nose. Specifically, the study is lookin...

Recruiting

Phase: PHASE3 Type: interventional Locations: Jinan, , China

TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma

NCT ID: NCT06912711

This clinical trial is studying a new treatment approach for patients with a specific type of nasopharyngeal carcinoma, which is a type of cancer located in the area behind the nose and above the b...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma

NCT ID: NCT06093061

This clinical trial, named RIBBON-LA-01, is studying the effects of a combination treatment using a drug called tislelizumab and a low-dose chemotherapy called metronomic capecitabine in patients w...

Recruiting

Phase: PHASE2 Type: interventional Locations: Singapore, , Singapore, Singapore, , Singapore

A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors

NCT ID: NCT06475300

This clinical trial is exploring a new treatment option for patients with locally advanced or metastatic non-small cell lung cancer, nasopharyngeal carcinoma, and other solid tumors. The study is t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China, Guangzhou, , China

A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors

NCT ID: NCT05956587

This clinical trial is studying a combination of two treatments, SI-B003 and BL-B01D1, to see how well they work in patients with advanced or spreading forms of non-small cell lung cancer and nasop...

Recruiting

Phase: PHASE2 Type: interventional Locations: Hangzhou, Zhejiang, China, Guangzhou, Guangdong, China +14 more

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

NCT ID: NCT06682442

This clinical trial is studying a new approach to treating nasopharyngeal carcinoma, a type of cancer linked to the Epstein-Barr virus (EBV). The trial compares a method called induction chemothera...

Recruiting

Phase: NA Type: interventional Locations: San Francisco, California, United States

Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC

NCT ID: NCT06752239

This clinical trial is studying a new approach to radiotherapy for patients with nasopharyngeal carcinoma, which is a type of cancer that occurs in the throat area behind the nose. The goal is to s...

Recruiting

Phase: PHASE3 Type: interventional Locations: Nanchang, Jiangxi, China

Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma

NCT ID: NCT05508347

This clinical trial is studying a new treatment approach for patients with locally advanced nasopharyngeal carcinoma (NPC), a type of cancer found in the area behind the nose. The trial is looking ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chendu, Sichuan, China

GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma.

NCT ID: NCT06851247

This clinical trial, called GAPP, is studying a new treatment approach for patients with advanced nasopharyngeal carcinoma, a type of cancer that affects the area behind the nose. Researchers want ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

CD70-targeted immunoPET Imaging of Malignant Cancers

NCT ID: NCT06852638

This clinical trial is looking at a new imaging method called CD70-targeted immunoPET/CT, which aims to help doctors spot certain types of cancers, including renal cancer (specifically clear cell r...

Recruiting

Phase: NA Type: interventional Locations: Shanghai, , China

Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC)

NCT ID: NCT06592599

This clinical trial is studying a new treatment combination for patients with a specific type of cancer called Epstein-Barr Virus (EBV) associated nasopharyngeal carcinoma (NPC). The researchers wa...

Recruiting

Phase: PHASE2 Type: interventional Locations: Palo Alto, California, United States

Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients

NCT ID: NCT06389201

This clinical trial is studying a new approach to treat advanced nasopharyngeal carcinoma (NPC), a type of throat cancer. Researchers are looking at whether a medication called HCQ, which can block...

Recruiting

Phase: NA Type: interventional Locations: Nantong, Jiangsu, China

A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma

NCT ID: NCT06629597

This clinical trial is studying a new treatment called YL201 for patients with recurrent or metastatic nasopharyngeal carcinoma, which is a type of cancer that affects the area behind the nose and ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Guangzhou, Guangdong, China

Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma

NCT ID: NCT05780372

This clinical trial is studying a new approach to treating nasopharyngeal carcinoma, a type of cancer that affects the area behind the nose and throat. The researchers want to find out if giving le...

Recruiting

Phase: PHASE3 Type: interventional Locations: Hangzhou, Zhejiang, China, Guangzhou, Guangdong, China +5 more

Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC

NCT ID: NCT06197776

This clinical trial is studying a new approach called "multi-omics technique" to see if it can help predict how well a combination of chemoradiotherapy (a treatment using chemotherapy and radiation...

Recruiting

Type: observational Locations: Guangzhou, Guangdong, China

Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC

NCT ID: NCT04544969

This clinical trial is looking at how well a specific type of cancer responds to treatment by studying circulating tumor cells (CTCs) in patients with metastatic nasopharyngeal carcinoma (mNPC). CT...

Recruiting

Type: observational Locations: Guangzhou, Guangdong, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions